Comparing eye fluid and tear markers before and after UCP
Part of Eyes & vision, Injuries & trauma clinical trials.
This study compares levels of inflammatory markers (cytokines) in the fluid inside your eye and your tears before and after a procedure called UCP (ultrasound cycloplasty) to treat glaucoma. It aims to understand how the eye responds, which may lead to better treatments for high eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glaucoma.
- Your eye pressure is either 21 mmHg or higher despite using maximum eye drops, or lower than 21 mmHg but your glaucoma is still getting worse.
- You do not have any other eye disease that affects eye pressure.
- You are not using steroid medications (pills or shots) before the procedure.
- You have not had glaucoma surgery in the past 3 months.
- You have not had an eye infection in the 2 weeks before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your eye's drainage angle changes after glaucoma surgery. It helps doctors understand what happens to the front part of your eye after procedures like laser or surgery to open the drainage area.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
This study collects eye fluid and tissue samples during planned cataract or combined cataract-glaucoma surgery to analyze differences between people with and without glaucoma. It may help researchers understand eye disease better.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This research study uses ultrasound imaging to examine the internal structures of the eye in people with angle-closure glaucoma (a type of increased eye pressure) and compares them to healthy eyes. Understanding these structures may help doctors better diagnose and treat this eye condition.
This trial tests a new medicine called HUC3-637 for people with primary open-angle glaucoma or ocular hypertension. It aims to see if it safely lowers eye pressure.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.